Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276221 · ClinicalTrials.gov registry record · NA
Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT03276221: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03276221 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03276221, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
This study will use a randomized controlled design to test whether 30 days of cannabis abstinence, compared to 30 days of monitoring, is associated with improvements in cognitive functioning. Non-using controls will also be enrolled to determine the clinical significance of any cognitive improvements with abstinence.
Interventions
- BEHAVIORAL Abstinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2017-08-07 |
| Est. Completion | 2022-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03276221
The ClinicalTrials.gov registry entry for NCT03276221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Abstinence is the first listed.
NCT03276221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03276221 about?
NCT03276221 is a clinical study titled "Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents". This study will use a randomized controlled design to test whether 30 days of cannabis abstinence, compared to 30 days of monitoring, is associated with improvements in cognitive functioning. Non-using controls will also be enrolled to determine the clinical significance of any cognitive improvement...
What is the current status of trial NCT03276221?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2017-08-07. Estimated completion is 2022-11-09.
What interventions are being tested in trial NCT03276221?
The interventions under investigation include: Abstinence (BEHAVIORAL).
Who is sponsoring clinical trial NCT03276221?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.